- Overall sales in the global market of cell and tissue analysis products were worth $2.6 billion in 2008, which increased to an estimated $2.8 billion in 2009. By 2014, it is projected to increase to $4.5 billion, for a 5-year CAGR of 10.1%.
- The largest segment of the market, cell and tissue characterization products was valued at $1.2 billion in 2008; this is expected to increase to $1.3 billion in 2009, and is projected to reach $2.2 billion in 2014, for a 5-year CAGR of 10.8%.
- Sales in the cell separation products segment amounted to $1.2 billion in 2008, increased to an estimated $1.3 billion in 2009, and is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 9.8%.
STUDY GOALS AND OBJECTIVES
This BCC Research report, Cell and Tissue Analysis Products: The Global Market, provides a detailed analysis of the products and technologies that define the market space and summarizes the composition and dynamics of individual companies in the competitive environment. The study also includes an overview of the relevant regulatory issues, patent landscapes, and strategic partnerships that will play a role in shaping the market in the future.
REASONS FOR DOING THE STUDY
The use of cells and tissue has been a mainstay of biomedical research since the isolation and propagation of the HeLa cell in the 1950s. Along with the recent emphasis on translational research in academia and demand for improved clinical models during drug development and screening, the current use of tissue and cells in the life sciences is at an all time high, creating intense demand for upstream isolation and downstream analytical products in industrial and academic markets.
Contemporary tissue repositories have vastly expanded their capacity and stock breadth. Technological advances in cellular engineering now have the ability to produce customized cell lines for specific research and industrial applications. In parallel, the cell remains at the center of experimental design in academia. All of these factors, as well as numerous others, have led to increased demand for products used to isolate and analyze cells and tissue.
The recent surge in NIH and NSF funding, $10.4 billion and $3 billion, respectively, stemming from President Obama’s stimulus package, will serve to drive novel and existing domestic research programs. As innovative projects get underway and new proposals are developed, the acute demand for products associated with life-science research will increase accordingly. As a corollary, due to the central role of cell and tissue analysis products in the life-science research flow, this market report will be particularly timely.
SCOPE OF REPORT
The study scope of this report includes commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable by 2014. Biospecimens, enzymatic, and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell based assays and products used in high content screening (HCS) platforms are included. Market growth forecasts through 2014 are presented.
In addition to examining larger and more established producers in cell and tissue analysis product market segments, BCC Research profiled numerous smaller specialized market players in this report. Market segmentation within the areas of biospecimen vendors, cell separation products and cell and tissue analysis products are highlighted. Each technology is also analyzed by application type and in the context of relevant technological and regulatory forces to determine its current market status and forecast growth through 2014. Recent industrial alliances and acquisitions affecting producer market penetration and dominance are also discussed.
BCC examines the structure of both the academic research and industrial end-user markets predominantly in the U.S., but also in key international markets. Important intellectual property holdings of industrial producers of cell and tissue analysis products are also discussed.
This report will be of general interest to business professionals in the field of biotechnology. Both life science reagent suppliers and research scientists will benefit from the comprehensive summary of relevant technologies and industrial profiles contained here. Consultants, strategic and market analysts, and investors working within the pharmaceutical, clinical and biotechnology industries will also find this report particularly useful. In addition, business development professionals, as well as those in sales, marketing, information sciences, and competitive intelligence fields of biotechnology will benefit from the information contained in this report.
METHODOLOGY AND INFORMATION SOURCES
The market assessments presented in this report were derived from publicly available information up to and including 2009-04-15. Using 2008 as the base year, forecast data are provided through 2014. In cases where data for 2009 were incomplete or not readily available, figures were extrapolated from 2008 statistics, half-year figures for 2008, and historical trends between 2004 and 2008. Market figures are based on current U.S. dollars with no adjustments for inflation made in the projections.
The information contained in this report has been assembled from both primary and secondary data sources. Primary research was conducted via telephone interviews with industry professionals, research scientists, physician-researchers, and laboratory heads to discover the most recent developments in their fields of interest. Secondary data was collected via a comprehensive search of the scientific, peer-reviewed literature, clinical trial reports and databases, industry trade media, company websites, annual reports, intellectual property databases, and industry press releases.
Dr. Willem Westra brings more than a decade of experience as an analyst in diverse areas of biomedical science, including basic research, intellectual property and investor relations to BCC Research. He is the author of several peer-reviewed scientific articles and book chapters and is a co-inventor of a recently patented method for characterizing and using stem cells. In addition to his academic research experience, Dr. Westra has served as an intellectual property/patent consultant, held visiting faculty positions, worked in the pharmaceutical and software industries in Silicon Valley and was a professional ski instructor. Dr. Westra earned both a B.S. in Pharmacological Chemistry and a Ph.D. in Biomedical Science from the University of California at San Diego.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.